| Send2Press.com • Today is Friday, July 03, 2009 | A Member of the Neotrope News Network |  |
 Search Send2Press.com: |
|
|
|
PRESS RELEASE : U.S. and World News :
Medical :
Fertility and IVF
News
|
|||||||||||||||||||||||||
|
Peoria Fertility Practice Welcomes New Physician
Fri, 03 Oct 2008, 18:58:48 EDT Edited by Carly Zander    Natalie Schultz, M.D. Joins Sher Institute for Reproductive Medicine PEORIA, Ill., Oct. 3 (SEND2PRESS NEWSWIRE) -- The Sher Institutes for Reproductive Medicine (SIRM(R)) have announced that Natalie Schultz, M.D. will assume the role of Medical Director of SIRM-Central Illinois, located in Peoria. Dr. Schultz brings to SIRM more than 20 years' experience in assisted reproductive technologies. She has been involved with top IVF programs in Chicago, Boston and Indianapolis, and has extensive clinical and academic experience with leading institutions including Harvard Medical School and the University of Texas. Dr. Schultz has been a pioneer in the field of infertility and has introduced new approaches to patient care. She has given numerous lectures and led seminar/support group series on Polycystic Ovary Syndrome (PCOS), educating women on lifestyle modifications that dramatically improve outcome and quality of life. "I am honored to be a member the SIRM family," said Dr. Schultz. "I hope to contribute to this center of excellence by adding my expertise and interest, especially in the area PCOS and functional medicine." SIRM-Central Illinois is part of the SIRM family of centers - one of the largest networks of infertility practices in the country and a leader in research in the field of infertility. Among the technologies that SIRM physicians have helped pioneer is a method for evaluating the chromosomal integrity of human eggs and embryos known as Comparative Genomic Hybridization (CGH). It is used to select the most viable embryos for use in the In Vitro Fertilization (IVF) process and has demonstrated the potential to significantly improve IVF success rates. This technology is now available in Central Illinois exclusively through the Sher Institute for Reproductive Medicine. Most recently, SIRM physicians and researchers have refined a method for the successful freezing of human eggs that has demonstrated post-thaw pregnancy rates of more than 6 times the current industry average. This is a significant development in the field of fertility preservation for women facing fertility-threatening cancer treatment or for women who are seeking to postpone childbearing for other reasons and face the challenges of the proverbial "biological clock." "It is very exciting to be part of a team that is known for outstanding patient care and is at the cutting edge of technology," added Dr. Schultz. "The staff here is very dedicated, caring, talented and totally invested in patient care, and it is a pleasure to be working alongside these individuals. I look forward to helping the couples here in Central Illinois make their dreams come true." About SIRM The Sher Institutes for Reproductive Medicine are a network of fertility centers that operate under a common management team and established set of cutting-edge medical protocols. The Sher Institutes for Reproductive Medicine were established in 1998 by Geoffrey Sher, who also founded the country's first private In Vitro Fertilization program in 1982. All SIRM centers are focused on providing individualized patient care in a caring and compassionate environment. In addition to the Peoria centers, SIRM has offices in St. Louis, Missouri; New York City, Westchester and Long Island, New York; Bedminster and Phillipsburg, New Jersey; Dallas, Texas; Los Angeles, Chino Hills, Sacramento, and Pleasanton California; and Las Vegas, Nevada. More information about SIRM can be found on the company website at www.haveababy.com. All trademarks acknowledged. Send2Press(R) is the originating wire service for this story, Copr. 2008. NEWS SOURCE: Sher Institute for Reproductive Medicine
NEWS SOURCE: Sher Institute for Reproductive Medicine
Send2Press® is the originating wire service for this story. Terms of Use
THE CONTENT OF THE ABOVE PRESS RELEASE WAS PROVIDED BY THE NEWS SOURCE, WHO IS SOLELY RESPONSIBLE FOR ITS ACCURACY. FOR QUESTIONS ABOUT THIS STORY CONTACT THE NEWS SOURCE AND NOT THIS WEBSITE (SEND2PRESS® NEWSWIRE).
Latest News from Send2Press Newswire:
Additional News on Similar Topics:
|
More News from this Company
Reader Resources
Main Send2Press® News Channels
Subscribe to Weekly News Alert
from Send2Press Newswire
|
|
|||||||||||||||||||||||
MEDIA READS (by media and public, as of today): 1352 times (2 today, 13 this week,
7 this month, 556 this year)
Site Design and Content is Copr. © 1983 - 2009 Neotrope® - All rights reserved. Send2Press® is a reg. trademark and service mark of NEOTROPE.
Press Release Writing | About Send2Press | Meet Our Staff | Contact Us | Our Services | Help Desk | Legal | Privacy | How-To Articles | RSS Feeds | Headline Feeds | Podcast | PR News Channels | Top-10 News | Success Stories | PRTRax™ Reader Tracking | Targeted News Distribution | Internet Marketing Services | Order PR Services | Terms of Service (TOS) |
|||||||||||||||||||||||||
Google
Reddit
Diigo
Delicious
Yahoo!
Digg
Blinklist
Blogmarks
Mixx
Facebook
Newsvine
